Skip to main content

Disorders of Ketogenesis and Ketolysis

  • Chapter
Inborn Metabolic Diseases

Zusammenfassung

Disorders of ketone body metabolism present either in the first few days of life or later in childhood, during an infection or some other metabolic stress. There are two defects of ketogenesis, 3-hydroxy-3-methylglutaryl (HMG)-CoA lyase deficiency and HMG-CoA synthase deficiency. In these, decompensation leads to encephalopathy, with vomiting and a reduced level of consciousness, often accompanied by hepatomegaly. The biochemical features – hypoketotic hypoglycaemia, with or without hyperammonaemia – resemble those seen in fatty acid oxidation disorders. The organic acids are diagnostic in HMG-CoA lyase deficiency. In HMG-CoA synthase deficiency, the organic acids are characteristic during decompensation but normal at other times. Ketone body utilisation is catalysed bysuccinyl-CoA:3-ketoacid CoA transferase (SCOT)and mitochondrial acetoacetyl-CoA thiolase (T2). Deficiencies of SCOT, T2 or the monocarboxylate transporter 1 (MCT1) present with episodes of ketoacidosis. This is often accompanied by dehydration and decreased consciousness. The organic acids usually show characteristic abnormalities in T2 deficiency but there are no specific findings in SCOT or MCT1 deficiencies and diagnosis relies on molecular analysis. In all these disorders, the primary aim of treatment is to prevent decompensation. Fasting is avoided and a high glucose intake is maintained at times of metabolic stress, such as infections. This chapter also briefly discusses the use of ketogenic diets in inherited metabolic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fukao T, Mitchell G, Sass JO et al. (2014) Ketone body metabolism and its defects. J Inherit Metab Dis 37:541–551

    Google Scholar 

  2. Pitt JJ, Peters H, Boneh A et al. (2015) Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: urinary organic acid profiles and expanded spectrum of mutations. J Inherit Metab Dis 38:459–466

    Google Scholar 

  3. Reimao S, Morgado C, Almeida IT et al. (2009) 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: initial presentation in a young adult. J Inherit Metab Dis 32:S49–52

    Google Scholar 

  4. Gibson KM, Cassidy SB, Seaver LH et al. (1994) Fatal cardiomyopathy associated with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. J Inherit Metab Dis 17:291–294

    Google Scholar 

  5. van der Knaap MS, Bakker HD, Valk J (1998) MR imaging and proton spectroscopy in 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency. AJNR Am J Neuroradiol 19:378–382

    Google Scholar 

  6. Pie J, Lopez-Vinas E, Puisac B et al. (2007) Molecular genetics of HMG-CoA lyase deficiency. Mol Genet Metab 92:198–209

    Google Scholar 

  7. Thompson GN, Chalmers RA, Halliday D (1990) The contribution of protein catabolism to metabolic decompensation in 3-hydroxy-3-methylglutaric aciduria. Eur J Pediatr 149:346–350

    Google Scholar 

  8. Langendonk JG, Roos JC, Angus L et al. (2012) A series of pregnancies in women with inherited metabolic disease. J Inherit Metab Dis 35:419–424

    Google Scholar 

  9. Fukao T, Scriver CR, Kondo N (2001) The clinical phenotype and outcome of mitochondrial acetoacetyl-CoA thiolase deficiency (beta-ketothiolase or T2 deficiency) in 26 enzymatically proved and mutation-defined patients. Mol Genet Metab 72:109–114

    Google Scholar 

  10. van Hasselt PM, Ferdinandusse S, Monroe GR et al. (2014) Monocarboxylate transporter 1 deficiency and ketone utilization. N Engl J Med 371:1900–1907

    Google Scholar 

  11. Ozand PT, Rashed M, Gascon GG et al. (1994) 3-Ketothiolase deficiency: a review and four new patients with neurologic symptoms. Brain Dev 16:S38–45

    Google Scholar 

  12. Paquay S, De Lonlay P, Dobbelaere D et al. (2015) Basal ganglia involvement in mitochondrial acetoacetyl-CoA thiolase deficiency. J Inherit Metab Dis 38:S187

    Google Scholar 

  13. Balasubramaniam S, Lewis B, Greed L et al. (2016) Heterozygous monocarboxylate transporter 1 (MCT1, SLC16A1) deficiency as a cause of recurrent ketoacidosis. JIMD Rep (in press)

    Google Scholar 

  14. Otonkoski T, Jiao H, Kaminen-Ahola N et al. (2007) Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. Am J Hum Genet 81:467–474

    Google Scholar 

  15. Merezhinskaya N, Fishbein WN, Davis JI et al. (2000) Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport. Muscle Nerve 23:90–97

    Google Scholar 

  16. Sasai H, Aoyama Y, Ohtsuka H et al. (2015) OXCT1 heterozygous carriers could develop severe ketoacidotic episodes in conjunction with ketogenic stress. J Inherit Metab Dis 38:S194

    Google Scholar 

  17. Fukao T, Maruyama S, Ohura T et al. (2012) Three Japanese patients with beta-ketothiolase deficiency who share a mutation, c.431A>C (H144P) in ACAT1: subtle abnormality in urinary organic acid analysis and blood acylcarnitine analysis using tandem mass spectrometry. JIMD Rep 3:107–115

    Google Scholar 

  18. Bennett MJ, Hosking GP, Smith MF et al. (1984) Biochemical investigations on a patient with a defect in cytosolic acetoacetyl-CoA thiolase, associated with mental retardation. J Inherit Metab Dis 7:125–128

    Google Scholar 

  19. Lutas A, Yellen G (2013) The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci 36:32–40

    Google Scholar 

  20. Kossoff EH, Zupec-Kania BA, Amark PE et al. (2009) Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 50:304–317

    Google Scholar 

  21. Klepper J, Leiendecker B (2013) Glut1 deficiency syndrome and novel ketogenic diets. J Child Neurol 28:1045–1048

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew A. M. Morris .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Morris, A.A.M. (2016). Disorders of Ketogenesis and Ketolysis. In: Saudubray, JM., Baumgartner, M., Walter, J. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49771-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-49771-5_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-49769-2

  • Online ISBN: 978-3-662-49771-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics